While the underlying metabolic dysfunction persists and would likely return if medication stopped, the daily reality for these individuals resembles non-diabetic glucose metabolism
You can read the abstract at Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial A group of researchers conducted a phase 3 clinical trial to examine the efficacy and safety of subcutaneous semaglutide 2.4 mg once per week, semaglutide 1.0 mg (licensed for the treatment of diabetes), and placebo in managing weight in an adult population who were overweight or obese and have type 2 diabetes
While traditional supplements often fall short, peptide therapy offers a precision-based medical approach to enhancing cellular repair and hormone signaling
Targets GLP-1 and GIP receptors, showing even greater weight loss than Ozempic in some studies
34 grams protein, 440 calories
BPC-157s stability in the gastric environment has made it a frequent subject in models of gut injury, ulcer formation and intestinal anastomosis